<p>CI confidence interval.</p><p>SCC squamous cell cancer.</p><p>Adeno adenocarcinoma.</p><p>Univariate and multivariate analysis for disease-free survival.</p
<p>ADC*: adenocarcinoma.</p><p>SCC*: squamous cell carcinoma.</p><p>OC*: other carcinomas, including...
<p>Univariate and multivariate analysis of overall survival in colorectal cancer patients.</p
<p>Univariate and multivariate survival analysis in patients with operable breast cancer.</p
<p>CI confidence interval.</p><p>SCC squamous cell cancer.</p><p>Adeno adenocarcinoma.</p><p>Univari...
<p>AD, adenocarcinoma; CEA, carcinoembryonic antigen; CI, confidence interval; HR, hazard ratio; n, ...
<p>*Statistically significant, <i>P</i><0.05; CI, confidence interval.</p><p>Univariate and multivar...
<p>Univariate and multivariate analysis of disease-free survival in 300 OSCC patients.</p
<p>Univariate and multivariate analysis of disease-free survival for aK-type.</p
<p>Univariate and multivariate analysis with respect to progression free survival in 22 triple-negat...
<p>Univariable and multivariable analysis with respect to disease-free survival in breast cancer.</p
<p>DFS, disease-free survival; OS, overall survival; FIGO, International Federation of Gynecology an...
Univariate and multivariate analyses for prediction factors for disease-free survival.</p
<p>Abbreviations: AD/ASC, adenocarcinoma/adenosquamous carcinoma; SCC, squamous cell carcinoma.</p><...
<p>HR, hazard ratio; CI, confidence interval; <sup>a</sup> Numbers of cases in each group; * Statist...
<p>Univariate and multivariate survival analysis for disease-free survival (DFS) and overall surviva...
<p>ADC*: adenocarcinoma.</p><p>SCC*: squamous cell carcinoma.</p><p>OC*: other carcinomas, including...
<p>Univariate and multivariate analysis of overall survival in colorectal cancer patients.</p
<p>Univariate and multivariate survival analysis in patients with operable breast cancer.</p
<p>CI confidence interval.</p><p>SCC squamous cell cancer.</p><p>Adeno adenocarcinoma.</p><p>Univari...
<p>AD, adenocarcinoma; CEA, carcinoembryonic antigen; CI, confidence interval; HR, hazard ratio; n, ...
<p>*Statistically significant, <i>P</i><0.05; CI, confidence interval.</p><p>Univariate and multivar...
<p>Univariate and multivariate analysis of disease-free survival in 300 OSCC patients.</p
<p>Univariate and multivariate analysis of disease-free survival for aK-type.</p
<p>Univariate and multivariate analysis with respect to progression free survival in 22 triple-negat...
<p>Univariable and multivariable analysis with respect to disease-free survival in breast cancer.</p
<p>DFS, disease-free survival; OS, overall survival; FIGO, International Federation of Gynecology an...
Univariate and multivariate analyses for prediction factors for disease-free survival.</p
<p>Abbreviations: AD/ASC, adenocarcinoma/adenosquamous carcinoma; SCC, squamous cell carcinoma.</p><...
<p>HR, hazard ratio; CI, confidence interval; <sup>a</sup> Numbers of cases in each group; * Statist...
<p>Univariate and multivariate survival analysis for disease-free survival (DFS) and overall surviva...
<p>ADC*: adenocarcinoma.</p><p>SCC*: squamous cell carcinoma.</p><p>OC*: other carcinomas, including...
<p>Univariate and multivariate analysis of overall survival in colorectal cancer patients.</p
<p>Univariate and multivariate survival analysis in patients with operable breast cancer.</p
DOI
Add to ORKG